EFFECTIVE AND SAFE DOSE OF INTRACORONARY NICORANDIL IN MAN

被引:2
作者
MIWA, K
IGAWA, A
YAMANISHI, K
FUJITA, M
INOUE, H
机构
[1] The Second Department of Internal Medicine, Toyama Medical, Pharmaceutical üniversity, Toyama 930-01
来源
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 1995年 / 59卷 / 11期
关键词
NICORANDIL; INTRACORONARY INJECTION; CORONARY CIRCULATION; CORONARY ARTERIOGRAPHY;
D O I
10.1253/jcj.59.736
中图分类号
N09 [自然科学史]; B [哲学、宗教];
学科分类号
01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;
摘要
Nicorandil is a hybrid of a nitrate and a potassium channel opener, and has a potent vasodilatory effect on coronary arteries. The effects of intracoronary injection of nicorandil on coronary circulation were examined in 12 adult patients with angiographically normal or near-normal left coronary arteries to determine the optimal dose of this agent. The intracoronary injection of nicorandil (up to 1 mg over 1 min) dilated left coronary artery segments in a dose-dependent manner, with no significant effects on systemic hemodynamic parameters. The percent increase in the epicardial coronary artery diameter with 1 mg nicorandil (31+/-5%, mean+/-SEM) was not significantly different from that with 0.3 mg sublingual nitroglycerin (39+/-5%). Coronary sinus venous oxygen saturation increased immediately after the intracoronary injection of 1 mg nicorandil, and then returned to the baseline level within 3 min. Neither arrhythmias nor conduction disturbances were observed. These results indicate that dilatation of the epicardial coronary artery was achieved with intracoronary nicorandil in a dose-dependent manner (up to 1 mg over 1 min) without any adverse effects in man, and the dilatory effect on coronary resistance vessels was of short duration.
引用
收藏
页码:736 / 744
页数:9
相关论文
共 22 条
[1]  
Austen W G, 1975, Circulation, V51, P5
[2]   SIMULTANEOUS MEASUREMENT OF CORONARY VENOUS-BLOOD FLOW AND OXYGEN-SATURATION DURING TRANSIENT ALTERATIONS IN MYOCARDIAL OXYGEN-SUPPLY AND DEMAND [J].
BAIM, DS ;
ROTHMAN, MT ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (04) :743-752
[3]  
BARDEAUX A, 1992, J CARDIOVASC PHAR S3, V20, pS17
[4]   A NEW METHOD FOR ASSESSMENT OF COLLATERAL DEVELOPMENT AFTER ACUTE MYOCARDIAL-INFARCTION [J].
FUJITA, M ;
OHNO, A ;
MIWA, K ;
MORIUCHI, I ;
MIFUNE, J ;
SASAYAMA, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (01) :68-72
[5]  
HASEBE N, 1990, European Heart Journal, V11, P386
[6]  
HASEBE N, 1990, THER RES, V11, P56
[7]   CORONARY EFFECTS OF NICORANDIL IN COMPARISON WITH NITROGLYCERIN IN CHRONIC CONSCIOUS DOGS [J].
HASHIMOTO, K ;
KINOSHITA, M ;
OHBAYASHI, Y .
CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 (01) :131-138
[8]  
HOSONO M, 1988, JPN J PHARM S, V46, P8
[9]   DETERMINATION OF EFFECTIVE AND SAFE DOSE FOR INTRACORONARY ADMINISTRATION OF NICORANDIL IN DOGS [J].
KOJIMA, S ;
ISHIKAWA, S ;
OHSAWA, K ;
MORI, H .
CARDIOVASCULAR RESEARCH, 1990, 24 (09) :727-732
[10]  
KREYE VAW, 1991, N-S ARCH PHARMACOL, V343, P70